Cerivastatin and reports of fatal rhabdomyolysis

N Engl J Med. 2002 Feb 14;346(7):539-40. doi: 10.1056/NEJM200202143460721.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Approval
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Pyridines / adverse effects*
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / mortality
  • United States / epidemiology
  • United States Food and Drug Administration

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyridines
  • cerivastatin